Patents by Inventor Chin-Yin TAI

Chin-Yin TAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF
    Publication number: 20220275072
    Abstract: The present disclosure relates to antibodies that bind selectively to pathological Tau, including compositions and methods relating to such antibodies, such as for treating tauopathies, neurodegenerative diseases associated with pathological aggregation of Tau.
    Type: Application
    Filed: March 30, 2022
    Publication date: September 1, 2022
    Applicant: APRINOIA THERAPEUTICS LIMITED
    Inventors: Ming-Kuei JANG, Chin-Yin TAI
  • Antibodies that bind to pathological Tau species and uses thereof
    Patent number: 11319365
    Abstract: The present disclosure relates to antibodies that bind selectively to pathological Tau, including compositions and methods relating to such antibodies, such as for treating tauopathies, neurodegenerative diseases associated with pathological aggregation of Tau.
    Type: Grant
    Filed: September 10, 2021
    Date of Patent: May 3, 2022
    Assignee: APRINOIA THERAPEUTICS LIMITED
    Inventors: Ming-Kuei Jang, Chin-Yin Tai
  • ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF
    Publication number: 20210403544
    Abstract: The present disclosure relates to antibodies that bind selectively to pathological Tau, including compositions and methods relating to such antibodies, such as for treating tauopathies, neurodegenerative diseases associated with pathological aggregation of Tau.
    Type: Application
    Filed: September 10, 2021
    Publication date: December 30, 2021
    Applicant: APRINOIA THERAPEUTICS LIMITED
    Inventors: Ming-Kuei JANG, Chin-Yin TAI
  • Antibodies that bind to pathological Tau species and uses thereof
    Patent number: 11149084
    Abstract: The present disclosure relates to antibodies that bind selectively to pathological Tau, including compositions and methods relating to such antibodies, such as for treating tauopathies, neurodegenerative diseases associated with pathological aggregation of Tau.
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: October 19, 2021
    Assignee: APRINOIA THERAPEUTICS LIMITED
    Inventors: Ming-Kuei Jang, Chin-Yin Tai
  • ANTIBODIES THAT BIND TO PATHOLOGICAL TAU SPECIES AND USES THEREOF
    Publication number: 20210163582
    Abstract: The present disclosure relates to antibodies that bind selectively to pathological Tau, including compositions and methods relating to such antibodies, such as for treating tauopathies, neurodegenerative diseases associated with pathological aggregation of Tau.
    Type: Application
    Filed: February 8, 2021
    Publication date: June 3, 2021
    Applicant: APRINOIA THERAPEUTICS INC.
    Inventors: Ming-Kuei JANG, Chin-Yin TAI